FI55650C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-(3,4-dimetoxifenetylamino)-3-fenoxy-2-propanolfoereningar - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-(3,4-dimetoxifenetylamino)-3-fenoxy-2-propanolfoereningar

Info

Publication number
FI55650C
FI55650C FI3180/72A FI318072A FI55650C FI 55650 C FI55650 C FI 55650C FI 3180/72 A FI3180/72 A FI 3180/72A FI 318072 A FI318072 A FI 318072A FI 55650 C FI55650 C FI 55650C
Authority
FI
Finland
Prior art keywords
propanolfoerening
dimetoxy
phenethylamino
phenoxy
pharmacological properties
Prior art date
Application number
FI3180/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI55650B (fi
Inventor
Ann Holmes
Robert Frederick Meyer
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Application granted granted Critical
Publication of FI55650B publication Critical patent/FI55650B/fi
Publication of FI55650C publication Critical patent/FI55650C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI3180/72A 1971-12-14 1972-11-14 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-(3,4-dimetoxifenetylamino)-3-fenoxy-2-propanolfoereningar FI55650C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
FI55650B FI55650B (fi) 1979-05-31
FI55650C true FI55650C (fi) 1979-09-10

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3180/72A FI55650C (fi) 1971-12-14 1972-11-14 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-(3,4-dimetoxifenetylamino)-3-fenoxy-2-propanolfoereningar

Country Status (21)

Country Link
US (1) US3857891A (en:Method)
JP (1) JPS5233621B2 (en:Method)
AR (2) AR195896A1 (en:Method)
AT (1) AT317182B (en:Method)
AU (1) AU475446B2 (en:Method)
BE (1) BE790165A (en:Method)
CA (1) CA993889A (en:Method)
CH (1) CH551371A (en:Method)
DK (1) DK134906B (en:Method)
ES (1) ES409565A1 (en:Method)
FI (1) FI55650C (en:Method)
FR (1) FR2163486B1 (en:Method)
GB (1) GB1344976A (en:Method)
HU (1) HU164953B (en:Method)
IE (1) IE37701B1 (en:Method)
IL (1) IL40833A (en:Method)
NL (1) NL150101B (en:Method)
NO (1) NO135244C (en:Method)
SE (1) SE393104B (en:Method)
YU (2) YU35871B (en:Method)
ZA (1) ZA727078B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (en:Method) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (en:Method) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
WO2000005193A1 (en) * 1998-07-23 2000-02-03 Chen Ing Jun GUAIACOXYPROPANOLAMINE DERIVATIVES WITH α/β-ADRENERGIC BLOCKING ACTIVITY
MXPA05001958A (es) 2002-08-19 2005-04-28 Pfizer Prod Inc Terapia de combinacion para enfermedades hiperproliferativas.
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
AU2014283319B2 (en) * 2013-06-19 2019-07-25 Som Innovation Biotech, S.L. Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (en:Method) * 1962-11-23
NL301580A (en:Method) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
YU293979A (en) 1981-04-30
IL40833A (en) 1976-01-30
US3857891A (en) 1974-12-31
SE393104B (sv) 1977-05-02
FR2163486B1 (en:Method) 1976-03-05
AU475446B2 (en) 1976-08-26
DK134906B (da) 1977-02-07
NL7216281A (en:Method) 1973-06-18
IL40833A0 (en) 1973-01-30
ZA727078B (en) 1973-06-27
YU35871B (en) 1981-08-31
ES409565A1 (es) 1975-12-01
AT317182B (de) 1974-08-12
IE37701B1 (en) 1977-09-28
NO135244B (en:Method) 1976-11-29
AU4918672A (en) 1974-05-23
AR198442A1 (es) 1974-06-21
JPS5233621B2 (en:Method) 1977-08-30
JPS4867232A (en:Method) 1973-09-13
DE2259489B2 (de) 1976-02-26
AR195896A1 (es) 1973-11-15
BE790165A (fr) 1973-02-15
CH551371A (fr) 1974-07-15
FR2163486A1 (en:Method) 1973-07-27
NO135244C (en:Method) 1977-03-09
CA993889A (en) 1976-07-27
GB1344976A (en) 1974-01-23
DK134906C (en:Method) 1977-06-27
HU164953B (en:Method) 1974-05-28
IE37701L (en) 1973-05-14
YU36007B (en) 1981-11-13
DE2259489A1 (de) 1973-07-05
FI55650B (fi) 1979-05-31
NL150101B (nl) 1976-07-15
YU301972A (en) 1981-02-28

Similar Documents

Publication Publication Date Title
FI55333C (fi) Foerfarande foer framstaellning av n-(1,1,1-trisubstituerade)-metylazoler
FI55186B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE382485B (sv) Anordning for framstellning av tunnveggiga bikakskonstruktioner.
MC921A1 (fr) Production de nucleosides de type 1,2,4-triazoli
FI56487B (fi) Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition
FI55650B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-(3,4-dimetoxifenetylamino)-3-fenoxy-2-propanolfoereningar
FI54299B (fi) Foerfarande foer framstaellning av saosom maskmedel verksamma 2-karbalkoxiamino-bensimidazol-5(6)-fenyletrar
FI56523B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull d-(4-amino-3-halogen)-2-alkylamino-etanol
FI55188B (fi) Foerfarande foer framstaellning av nya osymmetriska 1,4-dihydropyridindikarboxylsyraestrar
BE784076A (fr) Nouveaux derives d'acetophenonoxine
SE400167B (sv) Elementsats for astadkommande av mobler, skyltstell o d
FI54294B (fi) Foerfarande foer framstaellning av farmakologiskt verksamma isoindolinderivat
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
TR17956A (tr) 2,6-dinitroanilin herbisidler
FI56176B (fi) Foerfarande foer framstaellning av 2,4-diamino-5-bensylpyrimidiner
FI53921C (fi) Foerfarande foer granulering av tablettmassor i pulverform
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
FI55403C (fi) Anordning foer central uppvaermning av en lokal
SE398753B (sv) Forfarande for framstellning av 3',4'-didesoxitanamycin b
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
IT966299B (it) Procedimento per la produzione di i, i diantrachinonili e relativi flavantroni
FI56006B (fi) Analogifoerfarande foer framstaellning av farmakologiskt anvaendbara 2-imidazolidinonderivat
FI53821B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull 6-fenyl-8-klor-4h-s-triazolo(4,3-a)(1,4)bensodi-azepin-1-metanol
SE414306B (sv) Forfarande for framstellning av 1,4-bensodiazepiner